nalmefene associated_with vomiting
Evidence from:
primary |
all sources
Evidence (1 sources)
The adverse events reported most commonly with nalmefene (vs. placebo) were vomiting (8.7% vs. 2.3%)
confidence: 0.96
The adverse events reported most commonly with nalmefene (vs. placebo) were vomiting (8.7% vs. 2.3%)